Adage Capital Partners’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-846,000
Closed -$3.27M 1064
2026
Q1
$3.27M Hold
846,000
0.01% 808
2025
Q4
$3.54M Hold
846,000
0.01% 796
2025
Q3
$2.78M Sell
846,000
-10,430,000
-92% -$29.4M ﹤0.01% 783
2025
Q2
$16M Hold
11,276,000
0.03% 497
2025
Q1
$16.8M Buy
11,276,000
+410,595
+4% +$646K 0.03% 463
2024
Q4
$12.2M Hold
10,865,405
0.02% 557
2024
Q3
$10.3M Buy
+10,865,405
New +$13.7M 0.02% 598

Other funds holding PGEN

Adage Capital Partners's PGEN Position: Q2 2026 in Review

Adage Capital Partners sold out of Precigen (PGEN) in Q2 2026, closing a stake of 846,000 shares — an estimated $3.27M sold.

Adage Capital Partners first reported a position in PGEN in Q3 2024 and held it in 7 quarters. The position peaked at $16.8M in Q1 2025. 211 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • Adage Capital Partners reported no remaining Precigen position as of Q2 2026 after selling out during the quarter.
  • Adage Capital Partners sold 846,000 Precigen shares in Q2 2026, an estimated $3.27M.
  • Adage Capital Partners first reported a position in Precigen in Q3 2024 and held it in 7 quarters.
  • Adage Capital Partners's Precigen position peaked at $16.8M in Q1 2025.
  • 211 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Adage Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.